Bioresorbable Scaffolds Versus Metallic Drug-Eluting Stents: Are We Getting Any Closer to a Paradigm Shift?

Journal of the American College of Cardiology

Volumn 66, Issue 21, 2015, Pages 2310-2314

  Windecker, Stephan ^a   Koskinas, Konstantinos C ^a   Siontis, George C M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

bioresorbable scaffold; drug eluting stent; percutaneous coronary interventions

Indexed keywords

EVEROLIMUS; UMIROLIMUS; METAL;

ANGIOCARDIOGRAPHY; ARTERY DIAMETER; BIORESORBABLE SCAFFOLD; CHINA; CORONARY ARTERY DISEASE; DEVICE APPROVAL; DEVICE SAFETY; EVEROLIMUS ELUTING CORONARY STENT; EVIDENCE BASED MEDICINE; HEART INFARCTION; HUMAN; MEDICAL DEVICE COMPLICATION; MEDICAL RESEARCH; META ANALYSIS (TOPIC); NOTE; OPEN STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SCAFFOLD THROMBOSIS; STENT THROMBOSIS; TREATMENT OUTCOME; BIODEGRADABLE IMPLANT; DRUG ELUTING STENT; FEMALE; MALE; RADIOGRAPHY; STANDARDS; TISSUE SCAFFOLD;

ABSORBABLE IMPLANTS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; TISSUE SCAFFOLDS;

EID: 84962272489     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.10.002     Document Type: Editorial

References (19)

1. S. Windecker, S. Stortecky, G.G. Stefanini, and et al. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis BMJ 348 2014 g3859
2. J.P. Lane, L.E. Perkins, A.J. Sheehy, and et al. Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries J Am Coll Cardiol Intv 7 2014 688 695
3. M. Sabaté, S. Windecker, A. Iñiguez, and et al. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial Eur Heart J 2015 Sep 23 [E-pub ahead of print]
4. C.V. Bourantas, P.W. Serruys, S. Nakatani, and et al. Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data EuroIntervention 2014 Oct 14 [E-pub ahead of print]
5. S. Brugaletta, J.H. Heo, H.M. Garcia-Garcia, and et al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur Heart J 33 2012 1325 1333
6. P.W. Serruys, B. Chevalier, D. Dudek, and et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial Lancet 385 2015 43 54
7. K.C. Koskinas, Y.S. Chatzizisis, A.P. Antoniadis, and et al. Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation J Am Coll Cardiol 59 2012 1337 1349
8. J. Wiebe, H.M. Nef, and C.W. Hamm Current status of bioresorbable scaffolds in the treatment of coronary artery disease J Am Coll Cardiol 64 2014 2541 2551
9. P.W. Serruys, J.A. Ormiston, Y. Onuma, and et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
10. D. Capodanno, T. Gori, H. Nef, and et al. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicenter GHOST-EU registry EuroIntervention 10 2015 1144 1153
11. S. Brugaletta, T. Gori, A.F. Low, and et al. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION study J Am Coll Cardiol Intv 8 2015 189 197
12. R.P. Kraak, M.E. Hassell, M.J. Grundeken, and et al. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry EuroIntervention 10 2015 1160 1168
13. V. Kočka, M. Malý, P. Toušek, and et al. Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19' Eur Heart J 35 2014 787 794
14. T. Kimura, K. Kozuma, K. Tanabe, and et al. A randomized trial evaluating the everolimus-eluting Absorb bioresorbable scaffold vs. the everolimus-eluting metallic stent in patients with coronary artery disease: ABSORB Japan Eur Heart J 2015 Sep 1 [E-pub ahead of print]
15. S. Puricel, D. Arroyo, N. Corpataux, and et al. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds J Am Coll Cardiol 65 2015 791 801
16. R. Gao, Y. Yang, Y. Han, and et al. Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial J Am Coll Cardiol 66 2015 2298 2309
17. S. Windecker, P. Kolh, F. Alfonso, and et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 35 2014 2541 2619
18. A. Mattesini, G.G. Secco, G. Dall'Ara, and et al. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance J Am Coll Cardiol Intv 7 2014 741 750
19. L. Räber, S. Brugaletta, K. Yamaji, and et al. Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings J Am Coll Cardiol 66 2015 1901 1914